A new Covid-19 vaccine soon to be approved in Australia appears to be even better than all others on offer, with new data showing it could prevent all deaths from the virus.
Trial data from the UK shows the Novavax jab stops 96 per cent of infections and 100 per cent of serious illness and death from the original version of coronavirus.
Australia has ordered 51 million doses of the jab, but it has not yet been approved by regulators.
The vaccine was also about 86 per cent effective in stopping the more contagious UK strain of Covid-19, which has caused havoc in several Australian hotel quarantine systems.
It was about 90 per cent effective overall, combining data from people infected with both versions of the coronavirus.
In a smaller trial conducted in South Africa – where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world – the Novavax vaccine was only around 55 per cent effective at stopping infection but still fully prevented severe illness and death.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
Australia is currently rolling out the Pfizer and AstraZeneca jabs, which are both very effective at stopping serious illness.
People who have received a vaccine can be given another type of jab later if it proves to be a more effective combination.
It comes after Health Department boss Brendan Murphy confirmed all Australians will not get both jabs by October.
But Professor Murphy said a solitary shot of AstraZeneca’s Covid-19 jab – rather than two – will be enough to ‘completely vaccinate’ the population by then.
Speaking on Thursday, Professor Murphy admitted the target of four million vaccinations by next month also won’t be achieved.
He said ‘global supply issues’ with a number of European countries – including Italy blocking the export of a shipment of 250,000 doses to Australia – was the reason for the delay.
Australia had been expecting 3.8 million doses of AstraZeneca vaccine from Europe in March, but so far only 700,000 doses have arrived – leaving a 3.1 million shortfall.
The vaccine was also about 86 per cent effective in stopping the more contagious UK strain of Covid-19, which has caused havoc in several Australian hotel quarantine systems.
It was about 90 per cent effective overall, combining data from people infected with both versions of the coronavirus.
In a smaller trial conducted in South Africa – where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world – the Novavax vaccine was only around 55 per cent effective at stopping infection but still fully prevented severe illness and death.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
Australia is currently rolling out the Pfizer and AstraZeneca jabs, which are both very effective at stopping serious illness.
People who have received a vaccine can be given another type of jab later if it proves to be a more effective combination.
It comes after Health Department boss Brendan Murphy confirmed all Australians will not get both jabs by October.
But Professor Murphy said a solitary shot of AstraZeneca’s Covid-19 jab – rather than two – will be enough to ‘completely vaccinate’ the population by then.
Speaking on Thursday, Professor Murphy admitted the target of four million vaccinations by next month also won’t be achieved.
He said ‘global supply issues’ with a number of European countries – including Italy blocking the export of a shipment of 250,000 doses to Australia – was the reason for the delay.
Australia had been expecting 3.8 million doses of AstraZeneca vaccine from Europe in March, but so far only 700,000 doses have arrived – leaving a 3.1 million shortfall.
Image Credit: Novavax
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News
Completely New Use Discovered – This Traditional Herb Has Remarkable Nerve Regenerative Properties
Blessed thistle (Cnicus benedictus), a member of the Asteraceae family, thrives in our climate. This plant has been utilized for centuries as a medicinal herb, often consumed as an extract or tea to support [...]
Scientists study lipids cell by cell, making new cancer research possible
Imagine being able to look inside a single cancer cell and see how it communicates with its neighbors. Scientists are celebrating a new technique that lets them study the fatty contents of cancer cells, [...]
Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugs
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant worldwide challenge. A research group from China has [...]
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists clear a potential path toward earlier treatment for a disease that affects nearly 1,000,000 people in the United States. By Levi Gadye In a discovery that could hasten treatment for patients with multiple [...]
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
A study reveals that a new sequencing technique, tARC-seq, can accurately track mutations in SARS-CoV-2, providing insights into the rapid evolution and variant development of the virus. The SARS-CoV-2 virus that causes COVID has the unsettling [...]
No More Endless Boosters? Scientists Develop One-for-All Virus Vaccine
End of the line for endless boosters? Researchers at UC Riverside have developed a new vaccine approach using RNA that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised. Every [...]
How Are Hydrogels Shaping the Future of Biomedicine?
Hydrogels have gained widespread recognition and utilization in biomedical engineering, with their applications dating back to the 1960s when they were first used in contact lens production. Hydrogels are distinguished from other biomaterials in [...]
Nanovials method for immune cell screening uncovers receptors that target prostate cancer
A recent UCLA study demonstrates a new process for screening T cells, part of the body's natural defenses, for characteristics vital to the success of cell-based treatments. The method filters T cells based on [...]
New Research Reveals That Your Sense of Smell May Be Smarter Than You Think
A new study published in the Journal of Neuroscience indicates that the sense of smell is significantly influenced by cues from other senses, whereas the senses of sight and hearing are much less affected. A popular [...]
Deadly bacteria show thirst for human blood: the phenomenon of bacterial vampirism
Some of the world's deadliest bacteria seek out and feed on human blood, a newly-discovered phenomenon researchers are calling "bacterial vampirism." A team led by Washington State University researchers has found the bacteria are [...]
Organ Architects: The Remarkable Cells Shaping Our Development
Finding your way through the winding streets of certain cities can be a real challenge without a map. To orient ourselves, we rely on a variety of information, including digital maps on our phones, [...]
Novel hydrogel removes microplastics from water
Microplastics pose a great threat to human health. These tiny plastic debris can enter our bodies through the water we drink and increase the risk of illnesses. They are also an environmental hazard; found [...]
Researchers Discover New Origin of Deep Brain Waves
Understanding hippocampal activity could improve sleep and cognition therapies. Researchers from the University of California, Irvine’s biomedical engineering department have discovered a new origin for two essential brain waves—slow waves and sleep spindles—that are critical for [...]
The Lifelong Cost of Surviving COVID: Scientists Uncover Long-Term Effects
Many of the individuals released to long-term acute care facilities suffered from conditions that lasted for over a year. Researchers at UC San Francisco studied COVID-19 patients in the United States who survived some of the longest and [...]
Previously Unknown Rogue Immune Key to Chronic Viral Infections Discovered
Scientists discovered a previously unidentified rogue immune cell linked to poor antibody responses in chronic viral infections. Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in [...]
Nature’s Betrayal: Unmasking Lead Lurking in Herbal Medicine
A case of lead poisoning due to Ayurvedic medicine use demonstrates the importance of patient history in diagnosis and the need for public health collaboration to prevent similar risks. An article in CMAJ (Canadian Medical Association [...]